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Evidence is growing that secondhand smoke can cause death from several diseases. The association between
household exposure to secondhand smoke and disease-speciﬁc mortality was examined in two New Zealand
cohorts of lifelong nonsmokers (‘‘never smokers’’) aged 45–77 years. Individual census records from 1981 and
1996 were anonymously and probabilistically linked with mortality records from the 3 years that followed each
census. Age- and ethnicity-standardized mortality rates were compared for never smokers with and without home
exposure to secondhand smoke (based on the reported smoking behavior of other household members). Relative
risk estimates adjusted for age, ethnicity, marital status, and socioeconomic position showed a signiﬁcantly greater
mortality risk for never smokers living in households with smokers, with excess mortality attributed to tobacco-
related diseases, particularly ischemic heart disease and cerebrovascular disease, but not lung cancer. Adjusted
relative risk estimates for all cardiovascular diseases were 1.19 (95% conﬁdence interval: 1.04, 1.38) for men and
1.01 (95% conﬁdence interval: 0.88, 1.16) for women from the 1981–1984 cohort, and 1.25 (95% conﬁdence
interval: 1.06, 1.47) for men and 1.35 (95% conﬁdence interval: 1.11, 1.64) for women from the 1996–1999 cohort.
Passive smokers also had nonsigniﬁcantly increased mortality from respiratory disease. Sensitivity analyses in-
dicate that these ﬁndings are not due to misclassiﬁcation bias.
cohort studies; mortality; myocardial ischemia; neoplasms; New Zealand; respiratory tract diseases; tobacco
smoke pollution
Abbreviations: ICD-9, International Classiﬁcation of Diseases, Ninth Revision; SHS, secondhand smoke.
There is a substantial and growing body of evidence dem-
onstrating the adverse health consequences of exposure to
secondhand smoke (SHS) (1, 2). Adults exposed to SHS are
at increased risk of developing lung cancer (1–6), ischemic
heart disease (1, 2, 7–9), and stroke (10–12). Evidence is
mounting that passive smoking also increases the risk of
various respiratory diseases (1, 3, 10, 13).
A smaller collection of studies has examined mortality as
the principal outcome of interest among those exposed to
SHS. Cohort studies in the United States have produced
evidence that passive smokers are at increased risk of death
from ischemic heart disease (14–17), lung cancer (18, 19),
and all causes (17, 20, 21). Relatively few studies have ex-
amined the association between SHS and mortality in pop-
ulation cohorts outside the United States (3, 10, 22–26).
We present findings from two large New Zealand cohorts
of never smokers, describing the relation between exposure
to SHS in the home and mortality over the subsequent
3 years. Data on all-cause mortality have previously been
described in a short publication (27). Here, we report the
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relation between household exposure to SHS and mortality
from cardiovascular, respiratory, and malignant diseases. We
also describe sensitivity analyses undertaken to correct for
the effects of potential misclassification bias.
MATERIALS AND METHODS
Data sources
Data were derived from the New Zealand Census-
Mortality Study, the methodology and structure of which
are described in detail elsewhere (28). Briefly, two popula-
tion cohorts were created by linking individual records from
each of two New Zealand censuses (1981 and 1996) with
individual mortality records from the 3 years following each
census. Linkage was conducted anonymously and probabi-
listically by using sex, date of birth, ethnicity, country of
birth, and area of residence as matching variables. Overall,
about three quarters of all eligible mortality records were
linked to their corresponding census record (71.0 percent for
the 1981–1984 cohort and 78.2 percent for the 1996–1999
cohort) (29), with more than 97 percent of linked census-
mortality pairs estimated to be correct (30). The percentage
of mortality records linked to a census record varied by sex,
age, ethnicity, neighborhood deprivation, rurality, and cause
of death. (Deprivation was measured by an area-based index
calculated from census data on socioeconomic characteris-
tics (such as car access, housing tenure, and benefit receipt)
at aggregations of about 100 people and was assigned to
mortality data by using address (31).) Inverse probability
weights were therefore applied to adjust for linkage bias.
(For example, if records for 20 of 30 Maori male decedents
aged 45–64 years and residing in moderately deprived,
small areas of New Zealand were linked to a census record,
each of the 20 linked records received a weight of 1.5 (30/
20). Similar inverse probability weights were calculated and
applied to numerous strata (32).)
Study populations and exposure categories
The cohorts used in this study included persons aged 45–
74 years who responded to the 1981 and 1996 censuses,
identified themselves as lifetime nonsmokers, and lived in
a private dwelling (i.e., not a prison, hospital, or other in-
stitution). We excluded persons for whom data on smoking
status were not available for all other household members
aged 15 years or older (figure 1). The resultant study pop-
ulations comprised 87.0 percent of eligible never smokers
from the 1981 census and 85.3 percent from the 1996 census.
Study populations were divided into two categories ac-
cording to imputed SHS exposure in the home. Households
including at least one current smoker were regarded as
‘‘smoking,’’ and never smokers living in these households
were regarded as being exposed to SHS in the home. Never
smokers living in households with no current smokers
(‘‘nonsmoking’’ households) were regarded as unexposed
to SHS in the home.
Outcome measurement
Cause of death was derived from the death record accord-
ing to the International Classification of Diseases, Ninth
Revision (ICD-9). Disease-specific deaths were grouped as
follows: cardiovascular disease (ICD-9 codes 393–459), in-
cluding ischemic heart disease (ICD-9 codes 410–414) and
cerebrovascular disease (ICD-9 codes 430–438); lung can-
cer (ICD-9 code 162); respiratory diseases (ICD-9 codes
FIGURE 1. Questions on smoking from 1981 (top) and 1996 (bottom) New Zealand censuses.
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470–478 and 490–519); and non-lung cancers (ICD-9 codes
140–161 and 163–209).
Analyses
All-cause and disease-specific mortality rates were calcu-
lated for each cohort of never smokers according to SHS
exposure in the home. Mortality rates were controlled for
age and ethnicity by direct standardization, using the 1996
census population as the standard. Age standardization was
based on 5-year age bands and ethnicity standardization on
three prioritized ethnic groups (i.e., Maori, Pacific, and nei-
ther Maori nor Pacific).
Poisson regression was used to adjust for age, ethnicity,
marital status, and socioeconomic position (i.e., highest-
level qualification, labor force status, household equivalized
income, household car access, housing tenure, and small
area deprivation index). The study populations used in re-
gression analyses were slightly smaller than those used to
calculate mortality rates (comprising 85 percent of the
1981–1984 cohort and 91 percent of the 1996–1999 cohort)
because of missing data for some socioeconomic variables.
Statistical analyses were undertaken by using SAS ver-
sion 8.0 software (SAS Institute, Inc., Cary, North Carolina).
Sensitivity analyses
Sensitivity analyses were conducted to explore the effects
of possible misclassification of personal and household
smoking status on relative risk estimates. Sensitivity analy-
ses were undertaken by using crude data (person-time and
death counts were required) for all-cause mortality among
men from the 1996–1999 cohort. (Crude and adjusted rela-
tive risk estimates were very similar for all-cause mortality
in this group.)
Misclassiﬁcation of personal smoking status. On the basis
of previous research (33–36), we estimated that approxi-
mately 1.7 percent of current smokers and 6.8 percent of
former smokers misreported themselves as lifetime non-
smokers in the census. Since smokers tend to aggregate so-
cially, we assumed that this misreporting was more common
in smoking compared with nonsmoking households, at a ratio
of 3:1 (4).
From the above assumptions, we calculated the propor-
tions of misclassified current and former smokers in each
exposure group of our study cohort, using smoking status
data on all men aged 44–74 years in the 1996 census (refer to
the Appendix). Using observed mortality rates by smoking
status (Appendix), we then calculated the corrected num-
bers of persons and deaths by smoking status and SHS expo-
sure, the numbers of deaths among misclassified current and
former smokers, and (by subtraction) the corrected numbers
of deaths among nonsmokers within each exposure group.
Mortality by SHS exposure was recalculated by using these
corrected figures, yielding the ‘‘true’’ mortality rate ratio
adjusted for misclassification of personal smoking status.
Misclassiﬁcation of SHS exposure. Misclassification of
SHS exposure arises from three sources: misreported smok-
ing status by household members (leading to misclassifi-
cation of household smoking status), unmeasured SHS
exposure outside the home (meaning that household SHS
exposure will underestimate a person’s total SHS exposure),
and changes in SHS exposure over time. Considering these
sources, we estimated this study’s measure of SHS exposure
to have a sensitivity of about 88 percent and a specificity of
about 94 percent (refer to the Appendix for assumptions and
estimations). Corrected mortality rates and rate ratios were
calculated by using a method similar to that described by
Greenland (37): the estimated sensitivity and specificity of
the exposure measure were used to calculate corrected
person-years, deaths, and mortality rates in each exposure
group (Appendix).
RESULTS
The study cohorts comprised approximately 286,800 non-
smokers from the 1981 census and 381,462 from the 1996
census, with 23.2 percent and 14.5 percent, respectively, liv-
ing in households with at least one current smoker (table 1).
Nonsmokers living in smoking households tended to be
younger and were more likely to be married than those
living in nonsmoking households. The two exposure groups
had broadly similar income distributions, but persons from
smoking households were slightly less likely to have a post-
school qualification and slightly more likely to live in a de-
prived neighborhood. The prevalence of Maori and Pacific
peoples was higher in smoking households. There were 0.84
million person-years of observation and 10,188 deaths in the
1981–1984 cohort, and 1.13 million person-years of obser-
vation and 9,153 deaths in the 1996–1999 cohort (weighted
estimates) (table 2).
Mortality was higher among never smokers exposed to
SHS at home (table 2, figures 2 and 3), with mortality differ-
ences by household SHS exposure most pronounced for
women from the 1996–1999 cohort and least pronounced
for women from the 1981–1984 cohort. Mortality from car-
diovascular disease was higher for those with SHS exposure
in every study group except 1981–1984 women. Mortality
rates for ischemic heart disease and cerebrovascular disease
were similarly elevated for SHS-exposed persons in all but
the 1981–1984 group of women. Only a small number of
lung cancer deaths occurred in any of the study groups,
reflected in relatively low mortality rates. Deaths from re-
spiratory diseases were also few, although in all instances
mortality was higher in the SHS-exposed group. Mortality
from non-lung cancer tended to be higher among those per-
sons from smoking households.
Never smokers in smoking households had a consistently
elevated relative risk of death from cardiovascular and re-
spiratory diseases (table 3). Cardiovascular mortality risk was
significantly higher for passive smokers in all but the 1981–
1984 cohort of women, with rate ratios of 1.19 (95 percent
confidence interval: 1.04, 1.38) for men and 1.01 (95 percent
confidence interval: 0.88, 1.16) for women from the 1981–
1984 cohort, and 1.25 (95 percent confidence interval: 1.06,
1.47) for men and 1.35 (95 percent confidence interval: 1.11,
1.64) for women from the 1996–1999 cohort. Statistical
power was limited when cardiovascular mortality was bro-
ken down into more specific causes. Adjusted relative risk
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estimates for respiratory mortality ranged from 1.34 to 1.81,
although 95 percent confidence limits were generally wide.
Based on crude data for the 1996–1999 cohort of men, the
unadjusted relative risk of death from any cause was 1.14
(table 4). Correction for estimated misclassification of per-
sonal smoking status reduced this relative risk to 1.10. Cor-
rection for estimated misclassification of SHS exposure
increased the relative risk estimate to 1.24. When both types
of misclassification were corrected for simultaneously, the
resultant relative risk estimate was 1.18.
DISCUSSION
Data from two New Zealand cohorts of linked census
and mortality records show that never smokers who live
TABLE 1. Characteristics of 1981 and 1996 New Zealand census cohorts (never smokers aged 45–77 years) by sex and household
smoking status
Household
smoking status
1981 cohort 1996 cohort
Men Women Men Women
Nonsmoking Smoking Nonsmoking Smoking Nonsmoking Smoking Nonsmoking Smoking
Total no.* 72,504 19,578 147,822 46,893 131,163 21,450 194,958 33,891
Age (years) at census (%)
45–64 74.2 85.6 64.7 81.8 77.6 86.0 68.9 83.2
65–74 25.8 14.4 35.3 18.2 22.4 14.0 31.1 16.8
Ethnicity (%)
Maori 3.8 12.1 2.6 6.3 5.0 14.9 4.1 10.2
Paciﬁc 1.2 2.5 0.8 2.5 2.1 5.9 2.0 7.9
Non-Maori non-Paciﬁc 95.0 85.4 96.6 91.2 92.9 79.2 93.9 81.9
Marital status (%)
Currently married 81.6 87.1 64.7 85.4 80.9 86.0 69.7 80.7
Previously married 9.3 7.2 27.6 12.4 9.8 7.8 23.3 15.3
Never married 8.8 4.8 7.6 1.9 7.5 4.2 5.0 2.2
Missing 0.3 0.8 0.2 0.3 1.9 2.0 2.0 1.8
Highest qualiﬁcation (%)
Postschool 26.8 21.6 15.0 11.3 44.6 36.0 29.4 22.5
School 10.6 10.1 10.0 9.7 20.1 19.4 25.8 25.0
None 61.1 66.5 72.9 77.1 34.7 43.5 43.8 51.3
Missing 1.5 1.7 2.0 1.9 0.7 1.1 1.0 1.2
Household income (quintiles) (%)y
1 (highest) 25.3 26.9 18.3 22.5 28.0 26.4 20.4 21.4
2 19.6 21.4 15.6 20.3 20.6 22.5 18.1 21.7
3 17.0 16.2 14.7 17.0 16.9 19.7 16.1 20.6
4 15.4 11.5 17.6 14.1 15.2 10.4 23.2 12.6
5 (lowest) 11.8 6.8 22.9 10.3 13.5 9.7 16.6 12.6
Missing 10.9 17.0 10.8 15.8 5.8 11.2 5.7 11.1
Small-area deprivation (%)z
1–2 (least deprived) 23.9 19.7 21.3 18.1 29.6 21.8 26.7 20.4
3–4 22.3 20.1 21.3 20.2 23.5 20.2 22.9 19.5
5–6 20.7 19.4 21.3 21.0 19.5 19.2 20.5 19.9
7–8 18.8 20.1 20.0 20.7 15.9 19.0 17.5 20.0
9–10 (most deprived) 14.2 20.5 16.0 20.0 11.5 19.7 12.4 20.2
Missing 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
* Raw numbers were randomly rounded to the nearest or second nearest multiple of three, as per Statistics New Zealand’s protocol.
yHousehold income was equivalized by using the Luxembourg method (i.e., total household income divided by the square root of the number
of household members (59)) and categorized into quintiles based on its distribution over the whole census population.
zNew Zealand Deprivation Index, an index of material deprivation based on individual measures averaged across small geographically deﬁned
populations (31).
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with a smoker have higher rates of cardiovascular, respira-
tory, and overall mortality compared with those living in
smoke-free homes. Cardiovascular diseases (including is-
chemic heart disease and cerebrovascular disease) account
for the majority of excess mortality among those exposed to
SHS in the home. The large size of these cohorts enhances
the precision with which we were able to estimate the
mortality effect of passive smoking. Sensitivity analyses
TABLE 2. Number of person-years of observation, number of deaths, and standardized*mortality rates for 1981–1984 and 1996–1999
New Zealand cohorts (never smokers aged 45–77 years) by sex, cohort, and cause of death
Household
smoking status
1981–1984 cohort 1996–1999 cohort
Unweighted Weightedy Mortality ratez
(per 100,000 per year)
Unweighted Weightedy Mortality ratez
(per 100,000 per year)
Men
Person-years of
observation
Nonsmoking 214,047 211,852 389,120 387,292
Smoking 57,824 57,344 63,555 63,244
Deaths§
Total Nonsmoking 2,376 3,240 1,530.4 2,982 3,684 1,024.6
Smoking 579 846 1,683.6 522 687 1,198.3
Cardiovascular{ Nonsmoking 1,380 1,845 864.9 1,260 1,563 441.2
Smoking 321 459 982.8 228 303 540.3
Ischemic heart
disease
Nonsmoking 1,056 1,395 646.9 879 1,080 300.2
Smoking 216 300 646.7 147 192 320.8
Cerebrovascular Nonsmoking 174 243 112.3 165 210 60.9
Smoking 57 84 178.5 39 51 116.3
Lung cancer Nonsmoking 66 87 42.6 93 111 30.2
Smoking 18 24 41.4 18 21 43.8
Respiratory Nonsmoking 78 114 58.1 93 114 32.4
Smoking 24 39 59.3 21 27 55.8
Non-lung cancer Nonsmoking 513 681 312.2 1,032 1,245 339.8
Smoking 132 180 347.8 144 180 333.4
Women
Person-years of
observation
Nonsmoking 438,383 435,423 580,059 578,216
Smoking 139,400 138,675 100,796 100,507
Deaths§
Total Nonsmoking 3,555 4,902 1,009.8 3,333 4,026 671.6
Smoking 855 1,200 1,050.4 591 756 854.8
Cardiovascular{ Nonsmoking 1,716 2,358 475.4 993 1,212 205.0
Smoking 357 498 469.8 177 231 269.4
Ischemic heart
disease
Nonsmoking 1,083 1,458 286.8 564 681 113.6
Smoking 216 300 279.8 90 111 143.3
Cerebrovascular Nonsmoking 399 585 116.0 216 267 45.1
Smoking 69 102 101.9 33 45 52.2
Lung cancer Nonsmoking 48 69 17.5 102 129 20.9
Smoking 15 21 17.4 21 27 24.3
Respiratory Nonsmoking 87 126 30.3 111 138 24.6
Smoking 30 45 36.1 27 36 43.2
Non-lung cancer Nonsmoking 1,191 1,572 319.0 1,596 1,875 305.4
Smoking 321 435 344.6 264 321 374.7
* Standardized by age (5-year age bands) and ethnicity (Maori, Paciﬁc, and neither Maori nor Paciﬁc).
yWeighted to adjust for linkage bias by age, sex, ethnicity, small-area deprivation, rurality, and cause of death (32).
zMortality rates were calculated by using weighted data.
§ Raw numbers were randomly rounded to the nearest or second nearest multiple of three, as per Statistics New Zealand’s protocol.
{ Cardiovascular disease includes ischemic heart disease and cerebrovascular disease.
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indicate the increased mortality risk observed for passive
smokers is unlikely to be due to misclassification bias.
Our results are consistent with previous studies of SHS
exposure and cardiovascular disease, strengthening esti-
mates of cardiovascular mortality risk for passive smokers
(10, 14–17, 24). These data also add to the growing evidence
for an association between SHS exposure and adult respira-
tory disease (3, 10, 13).
The comparatively short duration of follow-up somewhat
limited our study’s power and means that it is probably best
suited to detecting increased mortality risk for diseases with
relatively acute mechanisms. Since our cohorts were created
by linking census and mortality records, duration of follow-
up was constrained by the need to maximize the accuracy
and success of record linkage (which tended to decline over
time). Unfortunately, we were not permitted to link records
across censuses. A 3-year follow-up is probably adequate
for deaths from cardiovascular diseases, where relevant bi-
ologic processes (increased platelet aggregation, impaired
endothelial function, and impaired oxygen delivery) are
triggered by relatively short-term exposure to environmental
tobacco smoke (38–42). However, our study is likely to have
underestimated the association between SHS and diseases
with a long latency (such as lung cancer), where the relevant
exposure probably occurred many years before this study
was undertaken. Had more detailed information been avail-
able on smoking intensity in each household, our analyses
might have been enhanced by testing for a dose-response
relation. The association between SHS exposure and in-
creased mortality risk becomes clearer with greater degrees
of aggregation (e.g., by grouping all cardiovascular deaths)
and is most consistently apparent for all-cause mortality
(reported previously by Hill et al. (27)).
A degree of exposure misclassification is inevitable (43).
Since we were unable to estimate SHS exposure outside the
home, our ‘‘nonexposed’’ study groups included a proportion
of persons with significant SHS exposure. The probable
effect of this misclassification is to dilute mortality differ-
ences between exposure groups, thus reducing the observed
association between SHS and mortality. The opposite effect
arises from misclassification of personal smoking status
(44): smokers misclassified as nonsmokers are more likely
FIGURE 2. All-cause and disease-speciﬁc mortality in 1981–1984 and 1996–1999 male New Zealand cohorts (nonsmokers aged 45–77 years)
by household exposure to secondhand smoke. Mortality rates (deaths per 100,000 per year) are standardized by age (5-year age bands) and
ethnicity (Maori, Paciﬁc, and neither Maori nor Paciﬁc). Vertical lines at the top of each column, 95% conﬁdence intervals. CVD, cardiovascular
disease (International Classiﬁcation of Diseases, Ninth Revision (ICD-9) codes 393–459); IHD, ischemic heart disease (ICD-9 codes 410–414);
Cerebrov, cerebrovascular disease (ICD-9 codes 430–438); Lung Ca, lung cancer (ICD-9 code 162); Resp, respiratory disease (ICD-9 codes 470–
478, 490–519); Non-lung Ca, non-lung cancer (ICD-9 codes 140–161, 163–209).
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to be found in households with other smokers (4), producing
a positive bias on the SHS-mortality association. We at-
tempted to address both kinds of misclassification through
sensitivity analyses, which suggest that the two tend to can-
cel one another out (table 4). Although our estimates were
based on a number of assumptions, we believe that we were
conservative in estimating bias due to unmeasured SHS ex-
posure outside the home. If this is the case (i.e., if significant
SHS exposure outside the home affects a greater proportion
of never smokers than we assumed in our calculations), the
true association between household SHS exposure and mor-
tality risk may be greater than reported here.
The absence of an observed association between SHS
exposure and lung cancer is probably a reflection of the
above limitations. Lung cancer has a long latency period,
and the relevant exposure in study participants will have
occurred some decades prior to our census-derived measure
of passive smoking. Misclassification of exposure will prob-
ably be greater for analyses of lung cancer mortality than for
mortality from diseases with a shorter latency. This effect is
exacerbated by our definition of ‘‘nonsmoking’’ households,
which will produce greater misclassification of past com-
pared with current SHS exposure (‘‘nonsmoking’’ house-
holds included those containing former smokers, which
would logically have been ‘‘smoking’’ households in the
past).
An interesting and perhaps surprising finding is the ap-
parently increased mortality from non-lung cancers in those
exposed to SHS (figures 2 and 3), with a significantly in-
creased risk of non-lung-cancer mortality among women
from the later cohort (table 3). Although lung cancer is
the malignancy most commonly coupled with smoking, to-
bacco smoke is also a major risk factor for other kinds of
cancer (45, 46), and there is evidence that passive smoking
increases the risk of all-cancer mortality (10). With refer-
ence to the US population, Glantz and Parmley (38) esti-
mated that non-lung cancers account for a greater proportion
of SHS-related deaths than does lung cancer. Nevertheless,
it is surprising that we found an association for non-lung
cancers but not lung cancer (both presumably having long
FIGURE 3. All-cause and disease-speciﬁc mortality in 1981–1984 and 1996–1999 female New Zealand cohorts (nonsmokers aged 45–77 years)
by household exposure to secondhand smoke. Mortality rates (deaths per 100,000 per year) are standardized by age (5-year age bands) and
ethnicity (Maori, Paciﬁc, and neither Maori nor Paciﬁc). Vertical lines at the top of each column, 95% conﬁdence intervals. CVD, cardiovascular
disease (International Classiﬁcation of Diseases, Ninth Revision (ICD-9) codes 393–459); IHD, ischemic heart disease (ICD-9 codes 410–414);
Cerebrov, cerebrovascular disease (ICD-9 codes 430–438); Lung Ca, lung cancer (ICD-9 code 162); Resp, respiratory disease (ICD-9 codes 470–
478, 490–519); Non-lung Ca, non-lung cancer (ICD-9 codes 140–161, 163–209).
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lag times). It may be that some non-lung cancers have a
shorter latency than lung cancer does and are thus less sub-
ject to misclassification of past SHS exposure. It is also pos-
sible that chance played some role in these results.
In keeping with other studies (47–52), we found lower
average educational levels and higher levels of neighbor-
hood deprivation among never smokers living with smokers.
Relative risk estimates were adjusted for a wide range of
socioeconomic variables, which are well recorded in the
New Zealand census. Other potential sources of confound-
ing (such as diet) could not be adjusted for directly; however,
given that these factors tend to be patterned by socioeco-
nomic position, their influence on relative risk estimates
should have been largely addressed in the above analyses
(47, 53, 54). It is possible that some confounding remains
from unmeasured risk factors, but, in our view, this factor is
unlikely to explain the results reported here. Unlike all-cause
mortality, few factors other than tobacco smoke would be
expected to raise mortality risk across the range of condi-
tions examined in this study (including cardiovascular dis-
ease, cancer, and nonmalignant respiratory disease).
The association between household SHS exposure and
mortality was notably stronger in the later cohort (1996–
1999). This finding may be explained by greater misclassi-
fication in the earlier cohort (1981–1984) due to greater
(unmeasured) SHS exposure outside the home. Potential
health risks from passive smoking were virtually unknown
in the early 1980s, and smoking was socially acceptable in
most circumstances (55); by the mid-1990s, public attitudes
and behavior had started to shift against exposure to other
people’s tobacco smoke (56). In 1990, the New Zealand
TABLE 3. Standardized* and adjustedy mortality relative risk estimates for nonsmokers living in smoking households, 1981–1984
and 1996–1999 New Zealand cohorts (never smokers aged 45–77 years) by sex, cohort, and cause of death
1981–1984 cohort 1996–1999 cohort
Standardized
RRz 95% CIz
Adjusted
RR
95% CI
Standardized
RR
95% CI
Adjusted
RR
95% CI
Men
All cause 1.10 0.99, 1.22 1.17 1.05, 1.30 1.17 1.05, 1.31 1.16 1.04, 1.30
Disease speciﬁc
Cardiovascular§ 1.14 0.99, 1.30 1.19 1.04, 1.38 1.22 1.03, 1.46 1.25 1.06, 1.47
Ischemic heart disease 1.00 0.85, 1.18 1.04 0.88, 1.23 1.07 0.86, 1.32 1.18 0.96, 1.44
Cerebrovascular{ 1.59 1.14, 2.21 1.91 1.23, 2.96 1.82 1.20, 2.77
Lung cancer{ 0.97 0.53, 1.77 1.08 0.56, 2.09 1.45 0.75, 2.81
Respiratory 1.02 0.62, 1.67 1.38 0.79, 2.42 1.72 0.99, 2.98 1.81 1.00, 3.28
Non-lung cancer 1.11 0.90, 1.38 1.19 0.95, 1.49 0.98 0.80, 1.20 0.98 0.80, 1.20
Women
All cause 1.04 0.96, 1.13 1.06 0.97, 1.16 1.27 1.15, 1.41 1.28 1.16, 1.42
Disease speciﬁc
Cardiovascular§ 0.99 0.87, 1.12 1.01 0.88, 1.16 1.31 1.09, 1.58 1.35 1.11, 1.64
Ischemic heart disease 0.98 0.83, 1.15 0.98 0.83, 1.17 1.26 0.98, 1.63 1.27 0.98, 1.66
Cerebrovascular 0.88 0.66, 1.17 0.90 0.67, 1.21 1.16 0.75, 1.79 1.17 0.76, 1.82
Lung cancer{ 1.00 0.49, 2.01 1.16 0.70, 1.92 1.38 0.78, 2.41
Respiratory 1.19 0.74, 1.92 1.34 0.81, 2.21 1.75 0.99, 3.10 1.59 0.95, 2.68
Non-lung cancer 1.08 0.94, 1.24 1.04 0.90, 1.21 1.23 1.06, 1.42 1.21 1.05, 1.40
* Standardized (directly) by age (5-year age bands) and ethnicity (Maori, Paciﬁc, and neither Maori nor Paciﬁc).
y Adjusted for age, ethnicity, marital status, and socioeconomic position (i.e., education, labor force status, household equivalized income,
household car access, housing tenure, and small-area deprivation index).
zRR, relative risk; CI, conﬁdence interval.
§ Cardiovascular disease includes ischemic heart disease and cerebrovascular disease.
{ Because of small numbers of deaths in some covariate substrata, we were unable to accurately calculate adjusted relative risk estimates for
cerebrovascularmortality in the1981–1984cohort ofmenor lung cancermortality in the1996–1999cohort ofmenand the 1981–1984cohort of women.
TABLE 4. Relative risk estimates for all-cause mortality in
men aged 45–77 years (1996–1999 New Zealand cohort):
unadjusted and adjusted for misclassiﬁcation of personal
smoking status and misclassiﬁcation of secondhand smoke
exposure
Misclassiﬁcation of
secondhand smoke
exposure
Unadjusted Adjusted
Misclassiﬁcation of
personal smoking status
Unadjusted 1.14 1.24
Adjusted 1.10 1.18
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Government passed legislation banning smoking in shared
workplaces and many public areas (57). These social and
legal changes mean that SHS exposure outside the home
was probably lower for our 1996–1999 cohort, resulting in
a less biased estimate of the association between home SHS
exposure and mortality. An alternative explanation for the
differing strength of association is a greater degree of un-
controlled confounding in the 1996–1999 cohort, which
might have occurred if household SHS exposure was more
strongly correlated with other unhealthy lifestyle factors in
later years. In our view, this is unlikely to be the main expla-
nation, given the modest change in relative risk estimates
with adjustment for socioeconomic position (which is
closely correlated with lifestyle (47, 53, 54)).
In summary, findings from two cohorts of never smokers
show increased cardiovascular, respiratory, and overall mor-
tality among nonsmoking adults exposed to SHS in the
home compared with those living in smoke-free homes. Ex-
cess mortality risk for passive smokers was not accounted
for by confounding or misclassification bias. These findings
add to the weight of evidence for a causal association be-
tween SHS and mortality from tobacco-related disease.
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APPENDIX
In the 1996 census, male respondents in the age group
44–74 years comprised 20.2 percent current smokers, 39.1
percent former smokers, and 40.7 percent never smokers.
Crude all-cause mortality rates (per 100,000 per year) were
1,645 among smokers, 1,397 among former smokers, and
788 among never smokers (59).
Calculating proportions of misclassiﬁed current and
former smokers in study exposure groups
The proportion of misclassified current and former smok-
ers in the unexposed cohort is given by the formula MU ¼
MTNT /(NU þ RNE), where MU is the proportion of misclas-
sified current and former smokers in the unexposed cohort,
MT is the proportion of misclassified current and former
smokers in the total cohort (i.e., unexposed plus exposed
cohorts), NT is the number of persons (or person-years of
observation) in the total cohort, NU is the number of persons
in the unexposed cohort, R is the ratio of misclassification in
exposed compared with unexposed cohorts (in this case
assumed to be 3:1), and NE is the number of persons in
the exposed cohort.
Estimated sensitivity and speciﬁcity of SHS exposure
categorization
Misclassification of SHS exposure arises from three
sources: misreported smoking status among household
members (leading to misclassification of household smok-
ing status), unmeasured SHS exposure outside the home
(meaning that household SHS exposure will underestimate
a person’s total SHS exposure), and changes in SHS expo-
sure over time. The first source of error will reduce sensi-
tivity by about 2 percent and specificity by about 1 percent
(an estimated 1.7 percent of current smokers misreport
themselves as nonsmokers (33); we assume that the propor-
tion of nonsmokers misreporting as current smokers is half
as much). The second source of error will further reduce
sensitivity by approximately 5 percent (a conservative ‘‘best
guess’’ for the proportion of nonsmokers in nonsmoking
households who have significant SHS exposure outside the
home). The specificity of our SHS exposure measure will be
unaffected. The third source of error we estimate to account
for a further 5 percent reduction in both sensitivity and
specificity, on the assumption that background SHS expo-
sure differed from exposure status at the time of measure-
ment for about 5 percent of nonsmoking census respondents.
(This last source of error will be greater in the case of dis-
eases with a long latency period (such as lung cancer),
where the relevant SHS exposure occurred some time prior
to exposure measurement.) These estimates yield an overall
sensitivity of 88 percent and specificity of 94 percent in our
study measure of SHS exposure.
Calculating study numbers corrected for
misclassiﬁcation of SHS exposure
Having assigned values to the sensitivity (Se) and speci-
ficity (Sp) of the exposure measure, the numbers of deaths in
the true exposed and true unexposed categories are given by
the following two formulae:
1. Ut ¼ (Er  SeEt)/(1  Sp)
2. Et ¼ (Ur(1  Sp)  SpEr)/((1  Se)(1  Sp)  SeSp),
where Et is the number of deaths among true exposed per-
sons, Ut is the number of deaths among true unexposed
persons, Er is the number of deaths among reported exposed
persons, and Ur is the number of deaths among reported
unexposed persons. The same two formulae can be used
to calculate numbers of persons (or person-years) in the true
exposed and true unexposed categories, using E and U to
represent numbers of persons (or person-years) in the ex-
posed and unexposed categories.
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